Holen Sie sich die Stockscreener-App
1.20
3.23%
-0.04
Vorhandelsmarkt:
1.15
-0.05
-4.17%
Schlusskurs vom Vortag:
$1.24
Offen:
$1.29
24-Stunden-Volumen:
8.18M
Relative Volume:
1.49
Marktkapitalisierung:
$20.22M
Einnahmen:
$12.99M
Nettoeinkommen (Verlust:
$-23.72M
KGV:
-0.0123
EPS:
-97.2514
Netto-Cashflow:
$-23.28M
1W Leistung:
-13.04%
1M Leistung:
-23.08%
6M Leistung:
-74.30%
1J Leistung:
-99.35%
1-Tages-Spanne:
$1.15
$1.29
1-Wochen-Bereich:
$1.15
$1.41
52-Wochen-Spanne:
$1.04
$298.00
Aptevo Therapeutics Inc Stock (APVO) Company Profile
Firmenname
Aptevo Therapeutics Inc
Sektor
Branche
Telefon
206-838-0500
Adresse
2401 4TH AVE., SEATTLE, WA
Vergleichen Sie APVO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
APVO
Aptevo Therapeutics Inc
|
1.20 | 20.89M | 12.99M | -23.72M | -23.28M | -97.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Aptevo Therapeutics Inc Stock (APVO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2018-11-05 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2017-10-05 | Fortgesetzt | Piper Jaffray | Overweight |
Aptevo Therapeutics Inc Aktie (APVO) Neueste Nachrichten
Prepare Yourself for Liftoff: Aptevo Therapeutics Inc (APVO) - Setenews
Aptevo Therapeutics Announces Promising RAINIER Trial Results - TipRanks
Aptevo Therapeutics Inc. (APVO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Aptevo’s AML therapy shows strong safety profile in phase 1b/2 trial - Investing.com
Aptevo Therapeutics Highlights Compelling Safety and Strong Remission Rates for Mipletamig in Frontline AML at ASH 2025 - ACCESS Newswire
Aptevo Therapeutics (NASDAQ: APVO) shows 100% CRS-free safety, 87% CR/CRi in AML - Stock Titan
Aptevo Therapeutics Inc Stock Analysis and ForecastVolatility Index Analysis & Daily Tips From Top Market Analysts - earlytimes.in
Aug Intraday: How analysts rate Aptevo Therapeutics Inc stock today2025 Earnings Surprises & Stock Timing and Entry Methods - BỘ NỘI VỤ
EBIT per share of Aptevo Therapeutics, Inc. – MUN:AP81 - TradingView
Targets Report: How Nevis Brands Inc 8DZ stock behaves under inflation pressureRate Hike & Daily Profit Maximizing Trade Tips - BỘ NỘI VỤ
Is Aptevo Therapeutics Inc (APVO) positioned for future growth? - Setenews
How Aptevo Therapeutics Inc. (AP81) stock behaves under inflation pressureJuly 2025 Pullbacks & Low Drawdown Investment Strategies - Newser
Aptevo Therapeutics (APVO) Stock Analysis Report | Financials & Insights - Benzinga
Is Aptevo Therapeutics Inc a good long term investmentDividend Growth Stocks & Low Entry Risk Stocks - earlytimes.in
Bombay Cycle Motor Agency Limited Recovery Hinges on Volume BreakoutCurrency Fluctuation Impact & Trusted Financial Advisors at No Cost - earlytimes.in
Aptevo Therapeutics (APVO) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - MSN
[EFFECT] Aptevo Therapeutics Inc. SEC Filing - Stock Titan
There is no way Aptevo Therapeutics Inc (APVO) can keep these numbers up - Setenews
[424B4] Aptevo Therapeutics Inc. Prospectus Filed Pursuant to Rule 424(b)(4) - Stock Titan
Aptevo Therapeutics reports Q3 EPS ($2.23) vs. ($357.86) last year - MSN
D pipelineMarket Trend Report & Risk Adjusted Buy/Sell Alerts - newser.com
Will Aptevo Therapeutics Inc. stock benefit from AI adoption2025 Pullback Review & Low Risk Growth Stock Ideas - newser.com
How Aptevo Therapeutics Inc. stock reacts to oil pricesAnalyst Upgrade & Advanced Swing Trade Entry Plans - newser.com
What macro factors could drive Aptevo Therapeutics Inc. (AP81) stock higherJuly 2025 Snapshot & Consistent Income Trade Recommendations - newser.com
Why Aptevo Therapeutics Inc. stock remains a top recommendationEarnings Recap Summary & High Conviction Buy Zone Alerts - newser.com
Can Aptevo Therapeutics Inc. (AP81) stock sustain breakout momentumWeekly Market Outlook & Accurate Intraday Trade Tips - newser.com
Why ETFs are accumulating Aptevo Therapeutics Inc. (AP81) stockTake Profit & Risk Adjusted Buy and Sell Alerts - newser.com
Combining machine learning predictions for Aptevo Therapeutics Inc.2025 Investor Takeaways & Weekly High Return Stock Opportunities - newser.com
Aptevo Therapeutics Inc. stock chart pattern explainedTrade Risk Assessment & Low Volatility Stock Suggestions - newser.com
How to escape a deep drawdown in Aptevo Therapeutics Inc.Quarterly Growth Report & AI Driven Stock Reports - newser.com
Smart tools for monitoring Aptevo Therapeutics Inc.’s price actionInflation Watch & Real-Time Buy Signal Alerts - newser.com
Using R and stats models for Aptevo Therapeutics Inc. forecastingTrade Exit Report & Safe Capital Growth Plans - newser.com
Finanzdaten der Aptevo Therapeutics Inc-Aktie (APVO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):